Tower Research Capital LLC (Trc) Calliditas Therapeutics Ab Transaction History

Tower Research Capital LLC (Trc)

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 10, 2022	BUY	$14.12 - $22.49 $43,941 - $69,988	3,112 Added 1270.2%	3,357 $51,000
Q2 2022 Aug 15, 2022	SELL	$12.85 - $20.36 $1,773 - $2,809	-138 Reduced 36.03%	245 $4,000
Q1 2022 May 12, 2022	SELL	$15.14 - $25.55 $7,766 - $13,107	-513 Reduced 57.25%	383 $7,000
Q4 2021 Feb 14, 2022	BUY	$15.04 - $26.32 $13,475 - $23,582	896 New	896 $22,000
Q2 2021 Aug 16, 2021	SELL	$26.02 - $31.17 $1,977 - $2,368	-76 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$27.01 - $32.92 $2,052 - $2,501	76 New	76 $2,000
Q3 2020 Nov 16, 2020	SELL	$21.61 - $25.69 $1,383 - $1,644	-64 Closed	0 $0
Q2 2020 Aug 13, 2020	BUY	$19.17 - $23.2 $1,226 - $1,484	64 New	64 $1,000

4.17K

Ticker CALT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 26,624,800
Market Cap $1.06B
Description
Calliditas Therapeutics AB (publ), a clinical-stage biopharmaceutical company, focused on identifying, developing, and commercializing pharmaceuticals products for treatments in orphan indications with initial focus on renal and hepatic diseases. It offers Nefecon, an oral formulation of budesonide that is an immunosuppressant for the treatment ...

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.